Mini Review: Effect of GLP-1 Receptor Agonists and SGLT-2 Inhibitors on the Growth Hormone/IGF Axis

Accumulating evidence supports the early use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium glucose transporter-2 inhibitors (SGLT-2is) for the treatment of type 2 diabetes. Indeed, these compounds exert numerous pleiotropic actions that favorably affect metabolism and diabetes c...

Descripción completa

Detalles Bibliográficos
Autores principales: Cignarelli, Angelo, Genchi, Valentina Annamaria, Le Grazie, Giulia, Caruso, Irene, Marrano, Nicola, Biondi, Giuseppina, D’Oria, Rossella, Sorice, Gian Pio, Natalicchio, Annalisa, Perrini, Sebastio, Laviola, Luigi, Giorgino, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899086/
https://www.ncbi.nlm.nih.gov/pubmed/35265043
http://dx.doi.org/10.3389/fendo.2022.846903

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899086/
https://www.ncbi.nlm.nih.gov/pubmed/35265043
http://dx.doi.org/10.3389/fendo.2022.846903

Ejemplares similares